Home/Filings/4/0001144204-11-021924
4//SEC Filing

Kanter Joshua 4

Accession 0001144204-11-021924

CIK 0001138776other

Filed

Apr 13, 8:00 PM ET

Accepted

Apr 14, 11:56 AM ET

Size

16.3 KB

Accession

0001144204-11-021924

Insider Transaction Report

Form 4
Period: 2011-04-13
Kanter Joshua
10% Owner
Transactions
  • Conversion

    2009 Convertible Debentures

    2011-04-1300 total(indirect: By Chicago Investments, Inc.)
    From: 2009-08-17Common Stock
  • Conversion

    2009 Convertible Debentures

    2011-04-1300 total(indirect: By Chicago Investments, Inc.)
    From: 2009-06-16Common Stock
  • Conversion

    2010 Convertible Debentures

    2011-04-1300 total(indirect: By Chicago Investments, Inc.)
    From: 2010-09-22Common Stock
  • Other

    Common Stock Warrants

    2011-04-13+8,3688,368 total(indirect: By Chicago Investments, Inc.)
    Exercise: $4.99From: 2011-04-13Exp: 2016-04-12Common Stock (8,368 underlying)
  • Conversion

    Common Stock

    2011-04-13+23,908621,997 total(indirect: By Chicago Investments, Inc.)
  • Conversion

    Common Stock

    2011-04-13+14,978636,975 total(indirect: By Chicago Investments, Inc.)
Footnotes (4)
  • [F1]The $15,000 Convertible Debenture, exercisable June 16, 2009, and the $50,000 Convertible Debenture, exercisable August 17, 2009, together with accrued interest thereon, automatically converted into shares of common stock of Medgenics, Inc. (the "Issuer") upon the closing of the Issuer's initial public offering in the U.S. based on a conversion price of $2.724 per share. The Convertible Debentures had no stated expiration date.
  • [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose.
  • [F3]The $50,000 Convertible, together with accrued interest thereon, automatically converted into shares of common stock of the Issuer upon the closing of the Issuer's initial public offering in the U.S. based on a conversion price of $3.405 per share. The Convertible Debenture had no stated expiration date.
  • [F4]The reporting person received these Common Stock Warrants in connection with the conversion of the 2009 Convertible Debentures.

Documents

1 file

Issuer

MEDGENICS, INC.

CIK 0001138776

Entity typeother

Related Parties

1
  • filerCIK 0001406480

Filing Metadata

Form type
4
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 11:56 AM ET
Size
16.3 KB